Valirx Share News (VAL)
VAL Share
VAL Share
VAL Share
VAL Share
VAL
VAL Share
VAL Level 2
VAL Live
VAL Broker
VAL Directors
VAL Financial
VAL
VAL Short
VAL
Last checked at -
ValiRx PLC - Nuneaton, England-based drug development company - Completes the evaluation of the impact of a peptide drug candidate against triple negative breast cancer. Evaluation concludes there is...
Read moreValiRx PLC - Nuneaton, England-based drug development company - Announces that the broker option granted to Turner Pope Investments Ltd has been fully subscribed and raises GBP1.0 million before expen...
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:...
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday....
Read moreFriday 24 June AFC Energy PLCGM re fees for non-executive directorsAvast PLCAGMDevolver Digital IncAGMEntain PLCAGMGulf Keystone Petroleum LtdAGMHawkwing PLCAGMInvesco Bond Income Plus LtdAGMLife...
Read more
(Sharecast News) - Cancer therapeutics and women's health-focussed ValiRx updated the market on its proposed sub-licensing agreement with TheoremRx for 'VAL201' on Friday....
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday....
Read more(Alliance News) - ValiRx PLC on Friday said it is expecting to be asked to extend the exclusivity period between itself and TheroemRx Inc regarding the proposed sub-licence of cancer treatment VAL201....
Read moreValiRx PLC - Nuneaton, England-based drug development company - Widens pretax loss in 2021 to GBP1.7 million from GBP1.5 million the previous year. Research and development costs rise 32% to GBP303,78...
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:...
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:...
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday....
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued Monday and not separately reported by Alliance News:...
Read moreAIM WINNERS & LOSERS: AdvancedAdvT buys into M&C Saatchi...
Read moreValiRx enters agreement and potential sub-license with TheoremRx...
Read more
Last checked at